Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

September 26, 2019

Study Completion Date

September 26, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Testosterone gel

Subjects receive a daily transdermal dose of 100 mg of testosterone (2 sachets of 5 g of gel) during 3 days.

DRUG

Ethanol Solution

Subjects receive a daily administration of 30 g of ethanol (94 mL of Vodka Absolut® diluted in 300 mL of lemon-flavoured water Fontvella®) during 3 days.

DRUG

Testosterone placebo (vaseline)

Subjects receive a daily transdermal dose of 5 g of pure vaseline ointment during 3 days.

DRUG

Ethanol placebo (lemon-flavoured water)

Subjects receive a daily administration of 394 mL of lemon-flavored-water Fontvella® during 3 days.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04166786 - Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption | Biotech Hunter | Biotech Hunter